Shenzhen Salubris Pharmaceuticals Co., Ltd. approved final cash dividend/10 shares (tax included) of CNY 5.00000000 for 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.06 CNY | -0.99% | -2.31% | -17.15% |
May. 22 | Salubris Pharmaceuticals Gets Nod to Market Hypertension Drug | MT |
Apr. 23 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.15% | 4.12B | |
+15.37% | 41.97B | |
+22.56% | 22.34B | |
+14.89% | 15.25B | |
+16.53% | 14B | |
+49.78% | 12.06B | |
-10.77% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- 002294 Stock
- News Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Shenzhen Salubris Pharmaceuticals Co., Ltd. Approves Final Cash Dividend for 2022